多面干预改善非洲裔美国人移植的移植结果差异 (MITIGAAT研究):随机对照试验的协议
Morgan Overstreet1, Hannah Culpepper1, Deanna DeHoff1
1Medical University of South Carolina, Charleston, SC, United States.
JMIR research protocols
|October 10, 2024
概括
这项研究研究了一种多式干预措施,通过改善药物服药和管理晚期临床问题来减少非裔美国人的移植差异. 目标是提高移植的存活率,减少医疗保健的使用率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植手术 移植手术
- 公共卫生 公共卫生
背景情况:
- 与白人接受者相比,非洲裔美国人移植接受者面临的移植损失率不成比例地高.
- 药物不坚持和高的塔克罗利斯变异性是导致移植损失的关键因素,特别是在移植后两年.
- 现有的研究强调了患者级数据的差距和提供者偏见,这些偏差加剧了这些种族差异.
研究的目的:
- 评估技术支持的,远程医疗提供的4级多式联络医疗服务干预对非洲裔美国人移植患者健康结果差异的影响.
- 改善药物坚持和控制晚期临床问题,从而减少移植结果的种族差异.
- 解决导致移植结果差异的患者,提供者和结构因素.
主要方法:
- 一个为期24个月的1:1随机对照试验 (MITIGAAT研究) 涉及190名参与者.
- 该干预是技术支持和远程医疗交付的,重点是坚持和控制塔克罗利斯变化,血压和葡萄糖的控制.
- 二次结果包括医疗保健利用率 (住院,急救诊所),成本效益分析,急性拒绝和移植存活率与全国队列相比.
主要成果:
- 该研究于2023年7月获得资金,招生于2024年4月开始,预计将于2026年完成,患者将于2028年底完成.
- 关于干预对坚持,临床结果,医疗保健使用和移植存活的影响的结果正在等待.
- 研究方案是为正在进行的临床试验而建立的.
结论:
- MITIGAAT研究协议概述了一种全面的方法,以解决移植中的种族差异.
- 多式联接干预旨在减轻导致移植损失的关键因素,并改善非洲裔美国受益人的长期结果.
- 进一步的结果将阐明这种远程医疗提供的干预措施在减少健康结果差异方面的有效性.
相关概念视频
01:28Kidney Transplant I: Introduction
2
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
2
01:16Kidney Transplant III: Nursing Management
3
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
3
01:26Kidney Transplant II: Surgical Procedure
2
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
2
01:24Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
01:22Bone Marrow Sampling and Transplants
312
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
312